Follow-up of Adolescents With Autism and Psychotic Symptoms - Psychiatric Co-morbidity and Functional Impairment.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-35
SponsorVärmland County Council, Sweden
About this trial
Purpose: To describe level of function, psychotic and psychiatric symptoms in a 10-year follow up of individuals with autism and psychotic symptoms.
Method: A case-control study based on a cohort of 48 teenagers with autism established 2013. In this study, 22 participant reported psychotic symptom in self-evaluation questionnaires design for early detection.
An additional 5 individuals were recruited in a second round of recruitment in 2019. Three of these individuals reported psychotic symptoms.
We aim to recruit individuals with psychotic symptoms and controls from the same cohort without psychotic symptoms. Data will be collected from self-rating scales, clinical evaluation including semi-structured interviews and healthcare journals.
The study is primarily descriptive, with group comparison by non-parametric method.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 15-18 at enrollment for the original study,
Autism spectrum disorder.
IQ>70.
Disqualifiers
None
Trial population
Participants are recruited from a prevoiusly established cohort (Region Värmland 2013) including 48 adolescents with autism. 22 participants reported psychotic symptom using self-assessment questionnaires. An additional 5 individuals were recruited in a second round of recruitment in 2019. Three of these individuals reported psychotic symptoms. Individuals with psychotic symptoms will be re-recruited along with controls from the same cohort without psychotic symptoms.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
None. Observational study.
Other interventionNone. Observational study.
Treatment groups
53 Participants
are divided into 2 treatment groupsGroup A: Cases1 intervention
Group B: Controls1 intervention
Trial outcomes
Primary outcomes
1
Number of participants with psychotic disease
Time frame
Single time point at enrollmentSecondary outcomes
1
Number of participants with non-psychotic psychiatric disease
Time frame
Single time point at enrollment2
Number of participants with psychotic symptoms without psychotic disease
Time frame
Single time point at enrollment3
Number of participants with functional impairment
Time frame
Single time point at enrollmentSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov